• Study Resource
  • Explore
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Current Status and Perspectives of Placebo
Current Status and Perspectives of Placebo

Prevention of Antiviral-Resistant HBV - HAL
Prevention of Antiviral-Resistant HBV - HAL

... Patients who develop lamivudine resistance are less likely to undergo hepatitis B e antigen (HBeAg) seroconversion. One study of 58 patients found that after 4-5 years of continued lamivudine therapy, HBeAg seroconversion was achieved in 38% of those with and 75%-80% of those without lamivudine resi ...
Dusano-ISAP-post
Dusano-ISAP-post

... biomarker and we can use a surrogate endpoint • While measuring the biomarker is straightforward, there are issues about the surrogate endpoint (discussed shortly) • Why do we do reasonably well with identifying exposure-response relationships in antiinfective trials? • The answer is that the MIC gi ...
Experimental Designs for Drug Combination Studies
Experimental Designs for Drug Combination Studies

... important that the experimental designs for such studies make use of all relevant available information in order to ensure statistically viable results and most efficient use of the available resources. Frequently used experimental designs require to collect data for the response of interest at diff ...
Chapter 14 – Mendel and the Gene Idea
Chapter 14 – Mendel and the Gene Idea

... He studied at the University of Vienna from 1851 to 1853, where he was influenced by a physicist who encouraged experimentation and the application of mathematics to science and by a botanist who stimulated Mendel’s interest in the causes of variation in ...
LABEL Infopest Verified
LABEL Infopest Verified

... Side effects: Carprofen is an NSAID, and as with others in the class, adverse reactions may occur with its use. Typical adverse reactions of NSAIDs include loss of appetite, vomiting, diarrhoea, melaena or faecal occult blood, and lethargy. Events involving suspected renal, haematological, neurologi ...
Rilpivirine: a new non-nucleoside reverse transcriptase inhibitor
Rilpivirine: a new non-nucleoside reverse transcriptase inhibitor

... efavirenz and nevirapine, are important components of highly active antiretroviral therapy. Combination therapy including an NNRTI has become a standard of care because of the low pill burden, improved adherence and high potency. Although NNRTIs are generally well tolerated, they also have a number ...
PDF
PDF

... ≤39 years, basal FSH levels ≤10 mIU/mL, normal uterine cavity, at least one patent tube and (for the male) 5 million motile spermatozoa. Patients with hypothalamic hypogonadism, hyperprolactinemia, thyroid dysfunction, body mass index (BMI) ≥30 kg/m2, and endometriosis were excluded. Each patient wa ...
EU Core Safety Profile
EU Core Safety Profile

... clinical trials were sedation and akathisia. In bipolar mania clinical trials, the most common adverse reactions were sedation, akathisia, extrapyramidal disorder and dizziness. The table below contains adverse events based on combined short term (4-6 week), fixed dose, schizophrenia studies and sho ...
chapter Anticholinergic Drugs Objectives
chapter Anticholinergic Drugs Objectives

... used before surgery and bronchoscopy. Drugs at a Glance: Selected Anticholinergic Drugs describes the therapeutic use, dosage and route of administration of selected anticholinergic medications. • GI disorders in which anticholinergics have been used include peptic ulcer disease, gastritis, pylorosp ...
PRODUCT MONOGRAPH ANAFRANIL - Sunovion Pharmaceuticals
PRODUCT MONOGRAPH ANAFRANIL - Sunovion Pharmaceuticals

... have been reported, the clinical significance of elevated serum prolactin levels is unknown for most patients. An increase in mammary neoplasms has been found in rodents after chronic administration of neuroleptic drugs. Neither clinical studies nor epidemiologic studies conducted to date, however, ...
FACTS ABOUT DRUGS
FACTS ABOUT DRUGS

... Possible side effects include heart related effects, asthma, bronchitis, damage to respiratory system and tissue, reddening of eyes, change in sex drive, infertility, changes in body temperature, hallucinations, slowed reaction time, delusions, panic, toxic psychosis, activation of latent schizophre ...
Enzyme Kinetics for Clinically Relevant CYP Inhibition
Enzyme Kinetics for Clinically Relevant CYP Inhibition

... Abstract: In vitro cytochrome P450 (CYP)-associated metabolic studies have been considered cost-effective for predicting the potential clinical drug-drug interactions (DDIs), one of the major attritions in drug development. The breakthroughs during the past decade in understanding the biochemistry o ...
Can Drugs Cause Depression? A Review of the Evidence
Can Drugs Cause Depression? A Review of the Evidence

... on the basis of the analysis, determined that the three variables described above were confounders. This type of determination is somewhat exploratory and requires confirmation by further studies. Several other studies have failed to find associations between the use of ,B-blockers and depression. O ...
Abstral sublingual tablet ENG SmPC
Abstral sublingual tablet ENG SmPC

... If adequate analgesia is achieved at the higher dose, but undesirable effects are considered unacceptable, an intermediate dose (using the 100 microgram sublingual tablet where appropriate) may be administered. During titration, patients can be instructed to use multiples of 100 microgram tablets an ...
Clinical pharmacology of anti-infectives and nonsteroidal_англ
Clinical pharmacology of anti-infectives and nonsteroidal_англ

... A. occurs primarily in patients under 30 years of age B. occurs with increased frequency in patients receiving concomitant ethambutol therapy C. *is probably due to the formation of a toxic hydrazine metabolite that binds to liver protein D. is frequently associated with allergic manifestations such ...
EU Core Safety Profile
EU Core Safety Profile

... clinical trials were sedation and akathisia. In bipolar mania clinical trials, the most common adverse reactions were sedation, akathisia, extrapyramidal disorder and dizziness. The table below contains adverse events based on combined short term (4-6 week), fixed dose, schizophrenia studies and sho ...
Human Genetic Revolution
Human Genetic Revolution

HIV Drugs and the HIV Lifecycle
HIV Drugs and the HIV Lifecycle

... final steps of putting together new virus particles (assembly). They also prevent the so-called budding of the new viruses out of the CD4 cell. There are no drugs of this type yet, but several candidates are in early studies. ...
Hypolipidemic Drugs
Hypolipidemic Drugs

... - chylomicrons transport TG and CHO from the GIT to the tissues, where they are split by lipase, releasing free fatty acids.There are taken up in muscle and adipose tissue. Chylomicron remnants are taken up in the liver - very low density lipoproteins (VLDL), which transport CHO and newly synthetise ...
mcqs for the final frca pain day - ffpmrca.co.uk
mcqs for the final frca pain day - ffpmrca.co.uk

... 13. Drugs that should be avoided in patients taking monoaminoxidase inhibitors (MAOIs) include: (a) Ephedrine. (b) Pethidine. (c) Morphine. (d) Bupivacaine with 1:200 000 adrenaline. (e) Ketamine. 14. Selective serotonin reuptake inhibitors: (a) May impair platelet function. (b) Are a contraindicati ...
PowerPoint Chapter 11
PowerPoint Chapter 11

... • First Generation – usually OTC, crosses blood-brain barrier, sedative effect • Dimetapp, Chlor-Trimeton, Benadryl, Banophen, Phernergan Second Generation – most available by prescription, some OTC, rapid onset, do not cross blood-brain barrier, do not cause excessive sedation ...
DEVELOPMENT AND CHARACTERIZATION OF CO-GROUND MIXTURES AND SOLID
DEVELOPMENT AND CHARACTERIZATION OF CO-GROUND MIXTURES AND SOLID

Drug study guide for NPLEX clincal
Drug study guide for NPLEX clincal

... Drug list for NPLEX 2 This list is NOT all inclusive of what is on NPLEX, but will likely have many NPLEX answers in it. I wrote this study list before taking NPLEX II examination. This list in no way tells people what specific questions were on nplex list, This list is based upon the 2009 NPLEX dru ...
ANTIHYPERLIPIDAEMIC DRUGS
ANTIHYPERLIPIDAEMIC DRUGS

... development, and it is possible that statins could cause serious problems). The effects of high cholesterol do not cause problems for many years or even decades. Therefore, if a woman does not take her statin or other cholesterol medications during breastfeeding, it will likely have only a minimal i ...
< 1 ... 367 368 369 370 371 372 373 374 375 ... 1254 >

Pharmacogenomics

Pharmacogenomics (a portmanteau of pharmacology and genomics) is the study of the role of genetics in drug response. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with drug absorption, distribution, metabolism and elimination, as well as drug receptor target effects. The term pharmacogenomics is often used interchangeably with pharmacogenetics. Although both terms relate to drug response based on genetic influences, pharmacogenetics focuses on single drug-gene interactions, while pharmacogenomics encompasses a more genome-wide association approach, incorporating genomics and epigenetics while dealing with the effects of multiple genes on drug response.Pharmacogenomics aims to develop rational means to optimize drug therapy, with respect to the patients' genotype, to ensure maximum efficacy with minimal adverse effects. Through the utilization of pharmacogenomics, it is hoped that drug treatments can deviate from what is dubbed as the “one-dose-fits-all” approach. It attempts to eliminate the trial-and-error method of prescribing, allowing physicians to take into consideration their patient’s genes, the functionality of these genes, and how this may affect the efficacy of the patient’s current and/or future treatments (and where applicable, provide an explanation for the failure of past treatments). Such approaches promise the advent of ""personalized medicine""; in which drugs and drug combinations are optimized for each individual's unique genetic makeup. Whether used to explain a patient’s response or lack thereof to a treatment, or act as a predictive tool, it hopes to achieve better treatment outcomes, greater efficacy, minimization of the occurrence of drug toxicities and adverse drug reactions (ADRs). For patients who have lack of therapeutic response to a treatment, alternative therapies can be prescribed that would best suit their requirements. In order to provide pharmacogenomic-based recommendations for a given drug, two possible types of input can be used: genotyping or exome or whole genome sequencing. Sequencing provides many more data points, including detection of mutations that prematurely terminate the synthesized protein (early stop codon).
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report